Hashim, Y. M., Vangveravong, S., Sankpal, N. V., Binder, P. S., Liu, J., Goedegebuure, S. P., . . . Hawkins, W. G. (2017). The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. J Exp Clin Cancer Res.

Hashim, Yassar M., Suwanna Vangveravong, Narendra V. Sankpal, Pratibha S. Binder, Jingxia Liu, S. Peter Goedegebuure, Robert H. Mach, Dirk Spitzer, and William G. Hawkins. "The Targeted SMAC Mimetic SW IV-134 Is a Strong Enhancer of Standard Chemotherapy in Pancreatic Cancer." J Exp Clin Cancer Res 2017.

Hashim, Yassar M., et al. "The Targeted SMAC Mimetic SW IV-134 Is a Strong Enhancer of Standard Chemotherapy in Pancreatic Cancer." J Exp Clin Cancer Res 2017.